US FDA limits use of Regeneron, Lilly Covid-19 antibody treatments, World News
US FDA limits use of Regeneron, Lilly Covid-19 antibody treatments, World News,The US health regulator revised on Monday (Jan 24) the emergency use authorizations for Covid-19 antibody treatments from Regeneron and Eli Lilly to limit their use, as the drugs are unlikely to work against the Omicron c
